First Citizens Financial Corp Bristol Myers Squibb CO Transaction History

First Citizens Financial Corp

  • $189 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 08, 2022
BUY
$72.62 - $79.98 $9,295 - $10,237
128 Added 3.14%
4,198 $323,000
Q3 2021

Oct 14, 2021
SELL
$59.17 - $69.31 $7,396 - $8,663
-125 Reduced 2.98%
4,070 $241,000
Q1 2021

Apr 09, 2021
SELL
$59.34 - $66.74 $126,750 - $142,556
-2,136 Reduced 33.74%
4,195 $265,000
Q4 2020

Feb 01, 2021
BUY
$57.74 - $65.43 $365,551 - $414,237
6,331 New
6,331 $393,000

Others Institutions Holding BMY

# of Institutions
2,428
Shares Held
1.5B
Call Options Held
29.7M
Put Options Held
32.2M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $113B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track First Citizens Financial Corp Portfolio

Follow First Citizens Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Citizens Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on First Citizens Financial Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email